Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

May 13, 2025
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • tumour cells

Tag: tumour cells

  • BiotechToday
  • World

CAR T Cells: Scientists discover ON/OFF switches for cell immunotherapy

bioxone January 18, 2021January 18, 2021 4

Sayak Banerjee, Amity University Kolkata CAR T cells are genetically modified immune cells that have been engineered to recognize and invade tumor cells. The immune T cells are collected and modified in the laboratory to generate finely-tuned chimeric antigen receptor, which identifies a distinctive protein on the surface of the patient’s cancer cells. The modified […]

Read More
  • BiotechToday
  • World

ENGINEERED ONCOLYTIC ADENOVIRUS TO TREAT METASTATIC CANCER

bioxone December 2, 2020December 2, 2020 4

Husna, Amity University Kolkata Oncolytic viruses are genetically engineered for the destruction of cancer or tumour-causing cells specifically. They’re delivered for treatment inside the body via intravenous injection. In 2015, one such oncolytic virus was approved by the FDA for treating skin cancer, melanoma. A major obstacle in the application of oncolytic adenoviruses is that […]

Read More
  • BiotechToday
  • World

NK cells can potentiate anti–tumour responses

bioxone November 25, 2020November 25, 2020

Prama Ghosh, Amity University Kolkata Past proof in mice has exhibited that NK cell-inferred IFN-gamma can advance immunoevasion by chiselling the immunogenicity of creating tumours in a process known as cancer immunoediting. This process includes the disposal of the high immunogenic unedited tumour, followed by the inevitable break of less immunogenic altered tumour cell variants […]

Read More
  • BiotechToday
  • India

SKIN CANCER KILLING BANDAGE DEVELOPED BY IISc

bioxone October 9, 2020October 9, 2020 2

Rohit Bhattacharjee, Amity University Kolkata Skin cancer, the most common kind of cancer, is mainly caused due to excessive exposure to the UV rays from the sun. They are of two types:- melanoma ( develops from pigment-producing skin cells called melanocytes) and non-melanoma (developed from other skin cells). Though non-melanoma skin cancer is more widespread, […]

Read More

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy